LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.21 | 21.74 | 4633 | 6235 | 0.7430 | 0.9285 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.21 | 21.74 | 4649 | 6235 | 0.7456 | 0.9294 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.21 | 21.74 | 523 | 6235 | 0.0839 | 0.4763 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.21 | 21.74 | 4404 | 6235 | 0.7063 | 0.9166 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.18 | 21.74 | 4838 | 6114 | 0.7913 | 0.9433 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.18 | 21.74 | 4862 | 6114 | 0.7952 | 0.9444 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.18 | 21.74 | 484 | 6114 | 0.0792 | 0.4643 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.18 | 21.74 | 4542 | 6114 | 0.7428 | 0.9282 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.15 | 21.74 | 5020 | 6167 | 0.8139 | 0.9501 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.15 | 21.74 | 5035 | 6167 | 0.8164 | 0.9508 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.15 | 21.74 | 504 | 6167 | 0.0817 | 0.4708 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.15 | 21.74 | 4666 | 6167 | 0.7565 | 0.9327 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.12 | 21.74 | 5264 | 6211 | 0.8474 | 0.9598 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.12 | 21.74 | 5281 | 6211 | 0.8502 | 0.9606 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.12 | 21.74 | 557 | 6211 | 0.0897 | 0.4882 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.12 | 21.74 | 4898 | 6211 | 0.7885 | 0.9426 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.09 | 21.74 | 5468 | 6201 | 0.8818 | 0.9694 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.09 | 21.74 | 5486 | 6201 | 0.8847 | 0.9702 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.09 | 21.74 | 563 | 6201 | 0.0908 | 0.4903 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.09 | 21.74 | 5002 | 6201 | 0.8066 | 0.9480 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.06 | 21.74 | 5625 | 6152 | 0.9143 | 0.9781 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.06 | 21.74 | 5646 | 6152 | 0.9177 | 0.9790 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.06 | 21.74 | 526 | 6152 | 0.0855 | 0.4788 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.06 | 21.74 | 5155 | 6152 | 0.8379 | 0.9570 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.03 | 21.74 | 5888 | 6155 | 0.9566 | 0.9891 | MN20160310_N01 | I11 |